Unique ID issued by UMIN | UMIN000006779 |
---|---|
Receipt number | R000008023 |
Scientific Title | Plastic stent placement above the sphincter of Oddi ("inside-stent") for patients of malignant hilar biliary obstruction. A prospective phase II trial. |
Date of disclosure of the study information | 2011/12/01 |
Last modified on | 2019/03/04 18:00:48 |
Plastic stent placement above the
sphincter of Oddi ("inside-stent") for
patients of malignant hilar biliary obstruction. A prospective phase II trial.
Plastic stent placement above the sphincter of Oddi ("inside-stent") for patients of malignant hilar biliary obstruction.
Plastic stent placement above the
sphincter of Oddi ("inside-stent") for
patients of malignant hilar biliary obstruction. A prospective phase II trial.
Plastic stent placement above the sphincter of Oddi ("inside-stent") for patients of malignant hilar biliary obstruction.
Japan |
Malignant hilar biliary obstruction
Hepato-biliary-pancreatic medicine |
Malignancy
NO
To evaluate the efficancy and safety of plastic stent placement above the sphincter of Oddi for patients of malignant hilar biliary obstruction.
Safety,Efficacy
Exploratory
Pragmatic
Phase II
Time to dysfunction
1.Dysfunction rate and substance
2.Complication rate and substance
3.Suvival time
4.Re-intervention rate and method
5.Operation time
6.success rate of operation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
A plastic stent which is attached a nylon string is used. The plastic stent is placed endoscopically above the sphincter of Oddi for malignant hilar biliary obstruction.
20 | years-old | <= |
Not applicable |
Male and Female
1.Unresectable malignant hilar biliary obstruction is proven by pathological or radiological diagnosis.
2.A stent placement is needed.
3.The therapy of a stent placement have never been performed.
4.Endoscopic stenting can be performed.
5.A stent can be placed above the sphincter of Oddi.
6.Written informed concent of the print.
1.The prognosis is considered within 3 months.
2.They have jaundice which can't be improved by stenting. For example, liver failure.
3.Decision of unsuitableness by principal investigator.
35
1st name | |
Middle name | |
Last name | Kazuya Sugimori |
Yokohama City University Medical Center
Gastroenterological Center
4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
045-261-5656
ycu.umin@gmail.com
1st name | |
Middle name | |
Last name | Tomohiro Ishii |
Yokohama City University Medical Center
Gastroenterological Center
4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
045-261-5656
tishii@yokohama-cu.ac.jp
Yokohama City University Medical Center
Gastroenterological Center
None
Self funding
NO
横浜市立大学附属市民総合医療センター(神奈川県)
神奈川県立がんセンター(神奈川県)
昭和大学藤が丘病院(神奈川県)
2011 | Year | 12 | Month | 01 | Day |
Unpublished
Terminated
2011 | Year | 11 | Month | 14 | Day |
2011 | Year | 12 | Month | 01 | Day |
2011 | Year | 11 | Month | 28 | Day |
2019 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008023